MedPath

Appendicostomy in rectal cancer

Not Applicable
Recruiting
Conditions
Rectal cancer.
Malignant neoplasm of overlapping sites of rectum, anus and anal canal
Registration Number
IRCT20180514039651N1
Lead Sponsor
Sari University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
52
Inclusion Criteria

Rectal adenocarcinoma confirmed by pathology
Patients with operable low or very low Rectal cancer or patients with operable high stage Rectal cancer after neoadjuvant therapy

Exclusion Criteria

Heart failure
Mental retardation
Diabetes
High dose Corticosteroid therapy
Immunodeficiency
Cases that have delay in wound healing

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Quality of life score of EORTC-QLQ-C30 (The European organization for research and treatment of cancer quality of life questionnaire). Timepoint: 3, 6, 12 months after surgery. Method of measurement: EORTC-QLQ-C30(The European organization for research and treatment of cancer quality of life questionnaire).;Evaluation of continence in Wexner questinnaire. Timepoint: 3, 6, 12 months after surgery. Method of measurement: Wexner questionnaire.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath